MedTrace Logo

South East (Zuid Oost) Netherlands Heart Registry

NCT06512493 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 99999

Last updated 2024-07-25

No results posted yet for this study

Summary

Rationale: Patients undergoing percutaneous coronary intervention (PCI) for chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) have a residual risk of ischemic events after PCI due to the progression of atherosclerosis in and outside the stented segments. The residual risk is affected by thrombotic, lipid, inflammation and diabetic risk factors. Secondary prevention after PCI is therefore of major importance to reduce complications and improve the patients' prognosis.

Objective: To provide an extensive overview on the quality of secondary prevention and personalized medicine, a consortium in the South East Netherlands has created a PCI registry, the "Zuid Oost Nederland Hart Registratie" (ZON-HR).

Conditions

Sponsors & Collaborators

  • Maastricht Universitair Medisch Centrum

    collaborator UNKNOWN

  • Zuyderland Medisch Centrum

    collaborator OTHER

  • VieCuri Medical Centre

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2050-01-01
Completion
2050-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06512493 on ClinicalTrials.gov